Pharmacy and Pharmaceutical Conference

Hydrogel-Based Delivery for Diabetes

Hydrogel-based delivery systems are a possible substitute for daily injections and constitute a substantial improvement in the treatment of diabetic Mellitus. This device delivers prolonged release of GLP-1 receptor agonists, which are essential for controlling blood glucose levels, using a biomimetic hydrogel depot. These injections, which might last for months and are made to fit with regular medical check-up schedules, lessen the burden of treatment on patients. This approach is more effective than daily injections at improving blood glucose control and weight control in laboratory rats, according to preliminary studies. The technology's versatility implies that it might be utilized for other therapeutic proteins and therapies, with the potential to revolutionize diabetes control and other related fields.

• Synthetic hydrogels
• Natural hydrogels